Initial disclosure notice – C Brockliss
Initial Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(1) and 298(1), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Green Cross Health Ltd
Date this disclosure made:
7-Apr-22
Date on which issuer listed or appointment made:
6-Apr-22
Director or senior manager giving disclosure
Full name:
Craig Michael Brockliss
Name of listed issuer:
Green Cross Health Ltd
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Director
Summary of relevant interest (excluding specified derivatives)
Class of quoted financial product:
Ordinary shares (NZX Code: GXH)
Number held in class:
583,747 11,091,195 113,717
Nature of relevant interest:
Craig is a beneficial owner of certain
shares held on bare trust by Wilton
Asset Management Ltd for Oscar
Holdings Ltd, his investment company
Craig is a director and joint
shareholder of the holding
company of Wilton Asset
Management Ltd, which holds
shares in Green Cross Health Ltd,
and Craig is therefore deemed to
have a relevant interest in those
shares
Craig is a beneficial owner of
certain shares held by Oscar
Holdings Ltd, his investment
company
Current registered holder: Wilton Asset Management LtdWilton Asset Management LtdOscar Holdings Ltd
Summary of specified derivatives relevant interest (if applicable)
Type of derivative:
n/a
Class of underlying financial products:
n/a
Details of derivative
The notional value of the derivative (if any) or the notional amount of underlying
products (if any):
n/a
A statement as to whether the derivative is cash settled or physically settled:
n/a
Maturity date of the derivative (if any):
n/a
Expiry date of the derivative (if any):
n/a
The price specified in the terms of the derivative(if any):
n/a
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
n/a
For that derivative,-
Parties to the derivative:n/a
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
n/a
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
7/04/2022
Name and title of authorised person:
Ben Doshi, Group CFO
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- NZX — NZX Limited: D&O Ongoing Disclosure Notice – Frank Aldridge2022-06-27
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: NZX Limited Date this disclosure made: 27-Jun-22 Date of last disclosure: 25-Mar-…”
- MEL — Meridian Energy Limited: D&O Initial Disclosures2022-05-31
“Initial Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(1) and 298(1), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Meridian Energy Limited Date this disclosure made: 31/05/2022 Date on which issuer…”
- NZX — NZX Limited: D&O Ongoing Disclosures – Multiple2022-03-25
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: NZX Limited Date this disclosure made: 25-Mar-22 Date of last disclosure: 25-Mar-…”